Dr. Paul Croarkin, Consultant and Associate Professor at the Mayo Clinic, and Dr. Jonathan Downar, Co-Director of MRI-Guided rTMS Clinic, University Health Network in Toronto, Canada, have joined an already-distinguished faculty.
SAN FRANCISCO, CA, June 15, 2017 /24-7PressRelease/ — TMS Health Education announced today it has added a fourth day to the Advanced Hands-on TMS Symposium and has invited two new TMS experts to join its faculty. “We’re thrilled to have the extra day and talented new faculty members for our symposium, as this has enabled us to add in some new tracks to the curriculum, build in more hands-on training, and increase the accredited psychiatry CME credits received by participants,” said Dr. Karl Lanocha, Director of Education for TMS Health Solutions and Course Chair for the Advanced Symposium.
Following the second Advanced Symposium held in October of 2016, TMS Health Education reviewed feedback from participants and noticed how well received the hands-on training had been. “We wanted to give our participants more training on each of the machines- and while we had done extensive training in small groups during our first two courses, we concluded an extra day would enable further hands-on time, ” said Dr. Richard Bermudes, course faculty for TMS Health Education and previous President of Clinical TMS Society. “Plus this would enable us to add a few more presentations,” he said.
New faculty members include Dr. Paul Croarkin, Consultant and Associate Professor at the Mayo Clinic, and Dr. Jonathan Downar, Co-Director of MRI-Guided rTMS Clinic, University Health Network in Toronto, Canada. All other faculty from the Fall 2016 will be returning to the Symposium. The renowned faculty is highly regarded in the field of TMS, and comes from extensive practice and research backgrounds with acclaimed teaching credentials from universities such as Duke, Medical University of South Carolina (MUSC), Stanford University and UCLA.
The course will include new content around using TMS in the treatment of other disorders other than major depression and in special populations along with accelerated TMS and novel pulse sequences. It will also include a review of TMS in the long-term management of depression. With new course work and further hands-on training, the CME credit will increase and there will be over twenty CME credits offered for the four-day completion.
About TMS Therapy
Cleared by the FDA in 2008, TMS is a drug-free, non-invasive therapy for patients who suffer from treatment-resistant depression. It is administered in a physician’s office in an outpatient setting. By using an MRI-strength magnetic field to stimulate the prefrontal cortex of the brain, the core symptoms of major depression can be relieved. Unlike antidepressants or Electroconvulsive Therapy (ECT), patients undergoing TMS therapy experience minimal side effects.
About TMS Health Education:
Headquartered in San Francisco, TMS Health Education is an education company that provides CME credits and continuing medical education and brings together the nation’s leading academics and clinical practitioners to present the most current and relevant information on the treatment of clinical depression illness through Transcranial Magnetic Stimulation (TMS) therapy. TMS Health Education is led by Dr. Richard Bermudes and Dr. Karl Lanocha, two of the nation’s leading experts on TMS therapy.
For the original version of this press release, please visit 24-7PressRelease.com here